Connect with us

Hi, what are you looking for?

Stock

Activist investor Bluebell takes stake in GSK

Stock Markets4 minutes ago (Sep 22, 2021 01:06PM ET)

(C) Reuters. FILE PHOTO: A GlaxoSmithKline plant is seen in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS/File Photo

(Reuters) -Activist investor Bluebell Capital Partners has taken a stake worth about 10 million euros in British pharmaceuticals group GlaxoSmithKline (NYSE:GSK) in efforts to shake up top management, a Financial Times report https://www.ft.com/content/539c077d-6ac2-4e79-9e0f-8080a31c5530 said on Wednesday.

Bluebell said in a letter to GSK Chairman Jonathan Symonds that chief executive Emma Walmsley should reapply for her job as she would have “renewed credibility both internally and externally”, the FT report said.

Earlier this year, activist Elliott had also taken a stake in GSK, calling for a leadership change at the company. Bluebell was largely backing Elliott’s demands, the FT said.

GSK confirmed Bluebell had made demands in a letter.

“We continue to engage extensively with our shareholders with over 500 meetings so far this year,” GSK said in a statement.

“They have expressed widespread and strong support for our plans to deliver a step-change in growth and performance, and given clear direction to focus on execution,” the company added.

The British pharma major, with a market value of over 71 billion pounds ($96.95 billion), in July rejected Elliott’s demands to change its board and sell its consumer healthcare arm.

GSK has set out plans to turn its consumer healthcare arm into a separately listed company, in a move that will deliver an 8 billion pound windfall and other financial benefits to boost drug development at its underperforming pharma business.

Bluebell was part of a successful investor campaign to oust Danone chairman and chief executive Emmanuel Faber in March.

($1 = 0.7323 pounds)

Activist investor Bluebell takes stake in GSK

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Uncategorized

Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt.

Uncategorized

Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione.

Uncategorized

Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem eum.

Uncategorized

Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora.

Disclaimer: Buzzclever.com it's managers and its employees (collectively "The Company") do not make any guarantee or warranty about what is advertised or above. Information provided by this website is for research purposes only and should not be considered as personalized financial or health advice. Copyright © 2021 Buzz Clever. All Rights Reserved